The Impact of Implementing a Pharmacist-led Deprescribing Program on Medication Adherence among Hemodialysis Patients
DOI:
https://doi.org/10.54133/ajms.v5i1S.290Keywords:
Adherence, Chronic kidney disease, Deprescribing practice, Hemodialysis, Iraqi patientsAbstract
Background: One way to target polypharmacy and inappropriate medication in hemodialysis (HD) patients is with medication deprescribing. Objective: To assess the impact of implementing a pharmacist-led deprescribing program on medication adherence among HD patients. Method: A prospective interventional, one-group pretest-posttest-only design study was conducted at a hemodialysis center in Wasit Governorate, Iraq. Medication reconciliation followed by medication review based on the deprescribing program was done for all eligible patients, and the patients were monitored for three months for any possible complications. Results: Two hundred and seventy patients were screened for eligibility. Only one hundred and eighteen were enrolled in the deprescribing program. The median age was 51.5 years, 56.8% were males, and hypertension was the most common etiology for their chronic kidney disease (CKD); 78% had comorbidities. After deprescription, there was a significant reduction in the number of medications from 6.0 to 4.0 and a reduction in the number of pills from 7.0 to 5.0. Medication adherence accessed using the Arabic version of Morisky, Green, and Levine’s (MGL) adherence scale also had a significant reduction from 2.0 to 1.0. Conclusion: A pharmacist-led deprescribing program is a successful strategy for decreasing the number of medications and daily pills prescribed while simultaneously improving hemodialysis patients' adherence to their regimens without compromising the patient’s safety.
Downloads
References
Lee SF, Chong CP. The influence of beliefs about medicines on medication nonadherence among hemodialysis patients: A multicenter study from Malaysia. East J Med. 2022;27(3):446-457. doi: 10.5505/ejm.2022.57804. DOI: https://doi.org/10.5505/ejm.2022.57804
Battistella M, Ng P. Addressing polypharmacy in outpatient dialysis units. Clin J Am Soc Nephrol. 2021;16(1):144-146. doi: 10.2215/CJN.05270420. DOI: https://doi.org/10.2215/CJN.05270420
Paneerselvam GS, Aftab RA, Sirisinghe RG, Mei Lai PS, Lim SK. Study protocol: Effectiveness of patient centered pharmacist care in improving medication adherence, clinical parameters and quality of life among hemodialysis patients. PLoS One. 2022;17(2):1-10. doi: 10.1371/journal.pone.0263412. DOI: https://doi.org/10.1371/journal.pone.0263412
Gerardi S, Sperlea D, Levy SOL, Bondurant-David K, Dang S, David PM, et al. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis. Am J Health Syst Pharm. 2022;79(4):S128-S135. doi: 10.1093/ajhp/zxac190. DOI: https://doi.org/10.1093/ajhp/zxac190
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57-65. doi: 10.1517/14740338.2013.827660. DOI: https://doi.org/10.1517/14740338.2013.827660
Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. The benefits and harms of deprescribing. Med J Aust. 2014;201(7). doi: 10.5694/mja13.00200. DOI: https://doi.org/10.5694/mja13.00200
Ghimire S, Castelino RL, Jose MD, Zaidi STR. Medication adherence perspectives in haemodialysis patients: a qualitative study. BMC Nephrol. 2017;18(1):1–9. doi: 10.1186/s12882-017-0583-9. DOI: https://doi.org/10.1186/s12882-017-0583-9
Murali KM, Lonergan M. Breaking the adherence barriers: Strategies to improve treatment adherence in dialysis patients. Semin Dial. 2020;33(6):475–85. doi:10.1111/sdi.12925. DOI: https://doi.org/10.1111/sdi.12925
Ghimire S, Castelino RL, Lioufas NM, Peterson GM, Zaidi STR. Nonadherence to medication therapy in haemodialysis patients: A systematic review. PLoS One. 2015;10(12):1–19. doi: 10.1371/journal.pone.0144119. DOI: https://doi.org/10.1371/journal.pone.0144119
Isenor JE, Bai I, Cormier R, Helwig M, Reeve E, Whelan AM, et al. Deprescribing interventions in primary health care mapped to the behavior change wheel: A scoping review. Res Soc Adm Pharm. 2021;17(7):1229–1241. doi: 10.1016/j.sapharm.2020.09.005. DOI: https://doi.org/10.1016/j.sapharm.2020.09.005
Dharmarajan TS, Choi H, Hossain N, Munasinghe U, Lakhi F, Lourdusamy D, et al. Deprescribing as a alinical improvement focus. J Am Med Dir Assoc. 2020;21(3):355–360. doi: 10.1016/j.jamda.2019.08.031. DOI: https://doi.org/10.1016/j.jamda.2019.08.031
Hernández-Prats C, López-Pintor E, Lumbreras B. Pharmacist-led intervention on the reduction of inappropriate medication use in patients with heart failure: A systematic review of randomized trials and non-randomized intervention studies. Res Soc Adm Pharm. 2022;18(5):2748-2756. doi: 10.1016/j.sapharm.2021.06.023. DOI: https://doi.org/10.1016/j.sapharm.2021.06.023
Bondurant-David K, Dang S, Levy S, Sperlea D, Vanier MC, Gerardi S, et al. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences. Int J Pharm Pract. 2020;28(6):635-642. doi: 10.1111/ijpp.12674. DOI: https://doi.org/10.1111/ijpp.12674
Jasim AL, Saleh ES, Abd Ali MN. Assessing the response of a sample of iraqi asthmatic patients to different medication regimens. Medico-Legal Updat. 2020;20(3):1119-1126. doi: 10.37506/mlu.v20i3.1552. DOI: https://doi.org/10.37506/mlu.v20i3.1552
Jasim AL, Saleh ES, Abd Ali MN. Evaluating the clinical outcomes of three medication regimens for treating a sample of Iraqi persistent asthmatic patients. Iraqi J Pharm Sci. 2020;29(1):154-165. doi: 10.31351/VOL29ISS1PP154-165. DOI: https://doi.org/10.31351/vol29iss1pp154-165
Atta RZ, Aloubaidy RM. Genetic polymorphism of asthma in Iraq. Iraqi J Agric Sci. 2022;53(2):288-296. doi: 10.36103/ijas.v53i2.1536. DOI: https://doi.org/10.36103/ijas.v53i2.1536
Alsaimary IE. Clinical findings of patients with human bronchial asthma in Basrah, Iraq. Appl Med Res. 2021;8(1):1-4. doi: 10.47363/amr/2021(8)190. DOI: https://doi.org/10.47363/AMR/2021(8)190
Mohammed SI, Mikhael EM, Ahmed FT, Al-Tukmagi HF, Jasim AL. Risk factors for occurrence and recurrence of diabetic foot ulcers among Iraqi diabetic patients. Diabet Foot Ankle. 2016;7:1-6. doi: 10.3402/dfa.v7.29605. DOI: https://doi.org/10.3402/dfa.v7.29605
Saleh BH, Ali SH, Allehibi KI. Serum aldosterone level in patients with diabetic nephropathy in relation to vascular calcification. Iraqi J Pharm Sci. 2019;28(1):53-63. doi: 10.31351/vol28iss1pp53-63. DOI: https://doi.org/10.31351/vol28iss1pp53-63
Jabbar TL, Kasim AA. Association of retinol binding protein- 4 (RBP4) with glycemia, dyslipidemia, hypertension, and obesity in type 2 diabetic Iraqi patients. Iraqi J Pharm Sci. 2021;29(2):263-270. doi: 10.31351/vol29iss2pp263-270. DOI: https://doi.org/10.31351/vol29iss2pp263-270
Hussein EA, Kadhim DJ, Al-Auqbi TF. Belief about medications among type 2 diabetic patients attending the National Diabetes Center in Iraq. Iraqi J Pharm Sci. 2017;26(2):66-74. DOI: https://doi.org/10.31351/vol26iss2pp66-74
Al-Rubaie HA, Hasan D. Assessment of hematological and biochemical parameters in hemodialysis patients and the impact of hemodialysis duration on hepcidin, ferritin and CRP. Iraqi J Hematol. 2014;3:85-97.
Talib AF, Mudhafar ZN. The role of clinical pharmacist in reducing drug related problems in hemodialysis patients. Iraqi J Pharm Sci. 2021;29(2):223-230. doi: 10.31351/vol29iss2pp223-230. DOI: https://doi.org/10.31351/vol29iss2pp223-230
Sadeq Joda R, Ibrahim MB, Al-Khafagi FA. Role of programmed cell death-1 and programmed cell death ligand-1 immune checkpoint biomarkers among chronic Hepatitis C virus patients under hemodialysis. J Fac Med Baghdad. 2023;65(2). doi: 10.32007/jfacmedbagdad.1989. DOI: https://doi.org/10.32007/jfacmedbagdad.1989
Al-Rubaie HA, Hasan DD, Al-Rubaye RA. Classification of anemia in hemodialysis patients in relation to vascular access and its correlation with hepcidin and ferritin. J Fac Med Baghdad. 2016;58(2):159-164. doi: 10.32007/jfacmedbagdad.582232. DOI: https://doi.org/10.32007/jfacmedbagdad.582232
Majeed YY, Al-Lami FH, Baldawi K, Ali AS. Haemodialysis services in Iraq in 2012: situation analysis, epidemiology and infrastructure. Iraqi New Med J. 2018;4(8):91-99.
Abdul-Jabbar MA, Kadhim DJ. Adherence to different treatment modalities among patients on maintenance hemodialysis. Iraqi J Pharm Sci. 2022;31(1):95-101. doi: 10.31351/vol31iss1pp95-101. DOI: https://doi.org/10.31351/vol31iss1pp95-101
Abdulrahman ZS, Alatrakji MQ, Al-Maliky AA, Hussein KI, Hussain SA. Influence of metformin dose and treatment adherence on glycemic control, adiposity, and cardiovascular risk markers in Iraqi patients with T2DM. J Fac Med Baghdad. 2022;64(4). doi: 10.32007/jfacmedbagdad.6441939. DOI: https://doi.org/10.32007/jfacmedbagdad.6441939
Awwad O, AlMuhaissen S, Al-Nashwan A, AbuRuz S. Translation and validation of the Arabic version of the Morisky, Green and Levine (MGL) adherence scale. PLoS One. 2022;17(10 October):1-14. doi: 10.1371/journal.pone.0275778. DOI: https://doi.org/10.1371/journal.pone.0275778
Butt MD, Ong SC, Butt FZ, Sajjad A, Rasool MF, Imran I, et al. Assessment of health-related quality of life, medication adherence, and prevalence of depression in kidney failure patients. Int J Environ Res Public Health. 2022;19(22). doi: 10.3390/ijerph192215266. DOI: https://doi.org/10.3390/ijerph192215266
Ghimire S, Peterson GM, Castelino RL, Jose MD, Zaidi STR. Medication regimen complexity and adherence in haemodialysis patients: An exploratory study. Am J Nephrol. 2016;43(5):318-324. doi: 10.1159/000446450. DOI: https://doi.org/10.1159/000446450
George JS, Joseph R, Thomas ETA, John GP, Siby A, Nair MM. Active deprescribing program in chronic kidney disease patients undergoing haemodialysis. Nephrology. 2021;26(11):890-897. doi: 10.1111/nep.13936. DOI: https://doi.org/10.1111/nep.13936
Zelko E, Klemenc-Ketis Z, Tusek-Bunc K. Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies. Mater Sociomed. 2016;28(2):129-132. doi: 10.5455/msm.2016.28.129-132. DOI: https://doi.org/10.5455/msm.2016.28.129-132
Neri L, Martini A, Andreucci VE, Gallieni M, Rocca Rey LA, Brancaccio D. Regimen complexity and prescription adherence in dialysis patients. Am J Nephrol. 2011;34(1):71-76. doi: 10.1159/000328391. DOI: https://doi.org/10.1159/000328391
Theofilou P. Medication adherence in Greek hemodialysis patients: The contribution of depression and health cognitions. Int J Behav Med. 2013;20(2):311-318. doi: 10.1007/s12529-012-9231-8. DOI: https://doi.org/10.1007/s12529-012-9231-8
Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75(11):1223-1229. doi: 10.1038/ki.2009.51. DOI: https://doi.org/10.1038/ki.2009.51
Chan YM, Zalilah MS, Hii SZ. Determinants of compliance behaviours among patients undergoing hemodialysis in Malaysia. PLoS One. 2012;7(8):1-7. doi: 10.1371/journal.pone.0041362. DOI: https://doi.org/10.1371/journal.pone.0041362
Schmid H, Hartmann B, Schiffl H. Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: A critical review of the literature. Eur J Med Res. 2009;14:185-190. DOI: https://doi.org/10.1186/2047-783X-14-5-185
Kitamura M, Yamaguchi K, Ota Y, Notomi S, Komine M, Etoh R, et al. Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis. Sci Rep. 2021;11:24238. doi: 10.1038/s41598-021-03772-0. DOI: https://doi.org/10.1038/s41598-021-03772-0
Wong MCS, Liu J, Zhou S, Li S, Su X, Wang HHX, et al. The association between multimorbidity and poor adherence with cardiovascular medications. Int J Cardiol. 2014;177(2):477-482. doi: 10.1016/j.ijcard.2014.09.103. DOI: https://doi.org/10.1016/j.ijcard.2014.09.103
Allaham KK, Feyasa MB, Govender RD, Musa AMA, Alkaabi AJ, Elbarazi I, et al. Medication adherence among patients with multimorbidity in the United Arab Emirates. Patient Prefer Adherence. 2022;16:1187-200. doi: 10.2147/PPA.S355891. DOI: https://doi.org/10.2147/PPA.S355891
Foley L, Larkin J, Lombard-Vance R, Murphy AW, Hynes L, Galvin E, et al. Prevalence and predictors of medication non-adherence among people living with multimorbidity: A systematic review and meta-analysis. BMJ Open. 2021;11(9):1-13. doi: 10.1136/bmjopen-2020-044987. DOI: https://doi.org/10.1136/bmjopen-2020-044987
Berglund E, Lytsy P, Westerling R. Living environment, social support, and informal caregiving are associated with healthcare seeking behavior and adherence to medication treatment: A cross-sectional population study. Health Soc Care Community. 2019;27(5):1260-1270. doi: 10.1111/hsc.12758. DOI: https://doi.org/10.1111/hsc.12758
Bouldin ED, Trivedi RB, Reiber GE, Rosland AM, Silverman JB, Krieger J, et al. Associations between having an informal caregiver, social support, and self-care among low-income adults with poorly controlled diabetes. Chronic Illn. 2017;13(4):239-250. doi: 10.1177/1742395317690032. DOI: https://doi.org/10.1177/1742395317690032
Look KA, Stone JA. Medication management activities performed by informal caregivers of older adults. Res Social Adm Pharm. 2018;14(5):418-426. doi: 10.1016/j.sapharm.2017.05.005. DOI: https://doi.org/10.1016/j.sapharm.2017.05.005
Ohya M, Iwashita Y, Kunimoto S, Yamamoto S, Mima T. An analysis of medication adherence and patient preference in long-term stable maintenance hemodialysis patients in Japan. 2019;(5):2595-603. doi: 10.2169/internalmedicine.2676-19. DOI: https://doi.org/10.2169/internalmedicine.2676-19
Klein KB, Pretto CR, Kleibert KRU, Campos F, Da Rosa MBC, Stumm EMF, et al. Adherence to drug treatments in patients with chronic kidney disease on hemodialysis. Mundo da Saude. 2019;43(4):800-813. doi: 10.15343/0104-7809.20194304800813. DOI: https://doi.org/10.15343/0104-7809.20194304800813
Reeve E, Wiese MD. Benefits of deprescribing on patients’ adherence to medications. Int J Clin Pharm. 2014;36(1):26-29. doi: 10.1007/s11096-013-9871-z. DOI: https://doi.org/10.1007/s11096-013-9871-z
Ulley J, Harrop D, Ali A, Alton S, Fowler Davis S. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: A systematic review. BMC Geriatr. 2019;19(1):1–13. doi: 10.1186/s12877-019-1031-4. DOI: https://doi.org/10.1186/s12877-019-1031-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).
